SEC Form 4 · accession 0001237899-17-000028
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
P Roy Vagelos
Officer — Chairman of the Board · Director
Period of report
Dec 11, 2017
Accepted (ET)
Dec 13, 2017 · 4:53 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 11, 2017 | M | 153,969 | $21.92 | A | 483,512 | D | |
| Common Stock | Dec 11, 2017 | F | 8,805 | $383.29 | D | 474,707 | D | |
| Common Stock | Dec 11, 2017 | F | 74,860 | $383.29 | D | 399,847 | D | |
| Common Stock | Oct 3, 2017 | G | 477 | $0.00 | D | 149,808 | I | by CLAT |
| Common Stock | Nov 7, 2017 | G | 91 | $0.00 | D | 149,717 | I | by CLAT |
| Common Stock | holding | — | — | — | 2,300 | I | By 401(k) Plan | |
| Common Stock | holding | — | — | — | 83,652 | I | by Spouse as Trustee | |
| Common StockF2 | holding | — | — | — | 1,203 | I | by trust for grandch |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F3 | $21.92 | Dec 11, 2017 | M | 153,969 | D | — | Dec 17, 2017 | Common Stock | 153,969 | 0 | D |
| Non-Qualified Stock Option (right to buy)F4 | $378.98 | Dec 12, 2017 | A | 74,390 | A | — | Dec 12, 2027 | Common Stock | 74,390 | 74,390 | D |
Explanation of responses
- F1Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- F2By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.
- F3The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
- F4The stock option award vests in four equal annual installments, commencing one year after the date of grant.